Towards Healthcare
AI in Biopharmaceuticals Market to Grow at 32.27% CAGR till 2034

AI in Biopharmaceuticals Market Reshaping Global Pharma Outlook

According to forecasts, the global AI in biopharmaceuticals market will grow from USD 1.55 billion in 2024 to USD 24.49 billion by 2034, with an expected CAGR of 32.27%. The implementation of artificial intelligence in biotechnology and pharmaceuticals helps to achieve speed and cost efficiency in drug discovery, precision medicine, clinical trials, manufacturing, and supply chain. North America dominated the market in 2024, driven by significant investments, R&D efficiency, and strategic partnerships and acquisitions.

  • Last Updated: 29 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

FAQ's

The AI in biopharmaceuticals market is valued at USD 2.05 billion in 2025 and is on track to reach USD 24.49 billion by 2034, witnessing a steady CAGR of 32.27% during the forecast span.

North America is currently leading the AI in biopharmaceuticals market share by 45% due to the collaborations between pharmaceutical companies and AI tech firms.

The AI in biopharmaceuticals market includes 5 segments such as application value-chain use, therapeutic focus use case, technology methodology, deployment delivery model, and region.

Key trends include accelerated drug discovery and development, optimization of clinical trials, precision medicine, and enhanced supply chain.

AHA, DoE, NSF, HHS, DARPA, EC, EU.